Benin vs Brazil: Cause of death, by non-communicable diseases, ages 15-59, female
Benin
49.3%
in 2021
Brazil
49.8%
in 2021
Benin rank
137th
Brazil rank
135th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Benin
- Brazil
How they compare
Brazil currently reports 49.8% against 49.3% in Benin, a difference of 0.5%.
Across all 6 years both countries report, Brazil has been ahead every year.
Benin ranks 137th and Brazil ranks 135th of 185 countries.
Brazil has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Benin | Brazil | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.2% | 74.8% | 39.6% | Brazil |
| 2010s | 48.6% | 75.4% | 26.8% | Brazil |
| 2020s | 50.6% | 57.7% | 7.1% | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Benin or Brazil?
- Brazil, at 49.8% against 49.3% in Benin as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Benin and Brazil?
- 0.5%, with Brazil ahead.
- How many years of comparable data are there for Benin and Brazil?
- 6 years are reported by both, from 2000 to 2021.
- How do Benin and Brazil rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Benin ranks 137th and Brazil ranks 135th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.